News

Leading global drug development consultancy Boyds has bolstered its US team with the appointment of experienced pharmaceutical product development professional Ami Patel PhD.


With more than 15 years’ experience in the pharmaceutical industry, Ami joins Boyds as Senior Director of Product Development based at the company’s Philadelphia office.

An independent study on European/UK growth stage Biotech remuneration

BioIVT, LLC (“BioIVT”), a leading global provider of biospecimens, cell and gene therapy related products, and research models and services for drug development purposes, today announced the promotion of Richard Haigh, PhD, to Chief Executive Officer (CEO) effective August 1. Dr. Haigh joined BioIVT in May 2022 as Chief Operating Officer and brings over 27 years’ experience in the life science research and diagnostics space covering products, consumables, and services, including over 15 years with Thermo Fisher Scientific/Life Technologies.

Cambridge UK: 27 July 2022


RSM UK has become the latest Partner to join forces with One Nucleus. The One Nucleus Partner Programme is tailor-made to meet the needs of One Nucleus Members, the Partner and One Nucleus in delivering on its core remit of supporting innovation.


Laragh Jeanroy, Managing Partner RSM East Anglia and Co-Head of Life Sciences at RSM commented

Author: Helen Baxter, Vice President, North Highland


I joined fellow Life Science enthusiasts at the OnHelix conference in Cambridge at the beginning of the month to listen and learn to some of the latest thinking in Innovation in the industry. A range of experts talked about BioInnovation in the pharma and biotech industry at the latest OnHelix conference in Cambridge July 2022. Here are some of the key themes that emerged from the conference.


  • Sian Steele appointed Chair of the Boards of Howard Investments and Howard Ventures

  • Andrew Hynard appointed Non-Executive Director


Cambridge, 28th July 2022: Cambridge-based property developer and investor Howard Group is pleased to announce Sian Steele as its new Board Chair. 


Sian will take up the position from 1st August after serving for the past two years as a Non-Executive Director of the Group.

Cpl Life Sciences UK is proud to have been part of the trailblazer groups for the first clinical research apprenticeships in industry – Clinical Trial Specialist degree apprenticeship (Level 6), and the Regulatory Affairs Specialist (Level 7) both launched in 2019. It is part of our ongoing work and commitment to ensure the worsening skills shortages in the UK life sciences sectors are addressed, through proactive initiatives and programmes to bring in new talent and upskill/reskill current workforces. We have always been passionate about ‘giving back’ and have dedic

One Nucleus Summer Life Sciences Dinner, Wednesday 6 July 2022


On the eve of our annual ON Helix Conference, we were pleased to welcome over 100 guests to attend the inaugural One Nucleus Summer Life Sciences Dinner on the stunning grounds of Babraham Research Campus.


The evening began with a networking drinks reception and once seated, Tony Jones, CEO, One Nucleus thanked the sponsors and guests for attending and supporting the evening.

Pages